Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jul;9(7):2221-31.
doi: 10.1002/j.1460-2075.1990.tb07392.x.

Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements

Affiliations

Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements

M Ponglikitmongkol et al. EMBO J. 1990 Jul.

Abstract

The synergistic action of the human estrogen receptor (hER) has been investigated using minimal promoters containing a TATA region and one or two estrogen responsive elements (EREs). We find that paired perfectly palindromic EREs act additively and independently of their relative spacing when positioned close to the TATA box. However, when moved 175 bp further upstream, perfectly palindromic EREs act synergistically and in a stereoalignment-dependent manner. Less efficient imperfectly palindromic EREs display a stereoalignment-dependent synergism even when positioned close to the TATA box. Analysis of binding in vitro of the hER to perfectly or imperfectly palindromic EREs by gel retardation and nitrocellulose filter binding assays does not provide any evidence for cooperative DNA binding. Conversely, the human progesterone receptor (hPR) clearly shows cooperative binding to paired responsive elements (PREs) under similar conditions in vitro. Thus, hER molecules bound to adjacent EREs must be properly stereoaligned to activate transcription synergistically in vivo. However, our data suggest that this synergism is not primarily due to cooperative binding to the EREs.

PubMed Disclaimer

References

    1. Trends Genet. 1988 Nov;4(11):309-14 - PubMed
    1. Mol Cell Biol. 1989 Jan;9(1):43-9 - PubMed
    1. EMBO J. 1989 Mar;8(3):823-9 - PubMed
    1. EMBO J. 1989 Jul;8(7):1981-6 - PubMed
    1. EMBO J. 1989 Aug;8(8):2257-63 - PubMed

Publication types